A technician prepares a flow cell slide for loading onto a genetic sequencing machine at a Regeneron Pharmaceuticals laboratory at the biotechnology company’s headquarters in Tarrytown, New York
Mike Segar | Reuters
Check out the companies making headlines in midday trading.
Regeneron — Shares of the biotech company rose 5.9% after President Donald Trump used Regeneron’s experimental antibody cocktail as part of his treatment for Covid-19. Cantor Fitzgerald upgraded the stock to overweight from neutral, citing potential growth from the antibody treatment and a dermatitis treatment.
CrowdStrike — Shares of CrowdStrike rallied more than 4% after Goldman Sachs upgraded